Abstract |
Characterizing the structural basis of ligand recognition of adenosine A2A receptor (AA2AR) will facilitate its rational design and development of small molecules with high affinity and selectivity, as well as optimal therapeutic effects for pain, cancers, drug abuse disorders, etc. In the present work, we applied our reported algorithm, molecular complex characterizing system (MCCS), to characterize the binding features of AA2AR based on its reported 3D structures of protein- ligand complexes. First, we compared the binding score to the reported experimental binding affinities of each compound. Then, we calculated an output example of residue energy contribution using MCCS and compared the results with data obtained from MM/GBSA. The consistency in results indicated that MCCS is a powerful, fast, and accurate method. Sequentially, using a receptor- ligand data set of 57 crystallized structures of AA2ARs, we characterized the binding features of the binding pockets in AA2AR, summarized the key residues that distinguish antagonist from agonist, produced heatmaps of residue energy contribution for clustering various statuses of AA2ARs, explored the selectivity between AA2AR and AA1AR, etc. All the information provided new insights into the protein features of AA2AR and will facilitate its rational drug design.
|
Authors | Jin Cheng, Maozi Chen, Siyi Wang, Tianjian Liang, Hui Chen, Chih-Jung Chen, Zhiwei Feng, Xiang-Qun Xie |
Journal | ACS chemical neuroscience
(ACS Chem Neurosci)
Vol. 12
Issue 9
Pg. 1606-1620
(05 05 2021)
ISSN: 1948-7193 [Electronic] United States |
PMID | 33856784
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adenosine A2 Receptor Agonists
- Adenosine A2 Receptor Antagonists
- Ligands
- Receptor, Adenosine A2A
- Adenosine
|
Topics |
- Adenosine
- Adenosine A2 Receptor Agonists
(pharmacology)
- Adenosine A2 Receptor Antagonists
(pharmacology)
- Ligands
- Protein Binding
- Receptor, Adenosine A2A
(metabolism)
|